Gastroesophageal Cancer Treatment Industry Forecast: Key Players and Growth Analysis 2022-2027

Gastroesophageal Cancer Treatment Market Projected to Expand at 15.8% CAGR Through 2027

The Global Gastroesophageal Cancer Treatment Market is projected to grow at around 15.8% CAGR during the forecast period, i.e., 2022-27. The growth of the market is driven primarily by the growing number of tobacco & alcohol consumers, lifestyle disorders, and the increasing prevalence of gastroesophageal reflux diseases (GERDs) & obesity.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

If you’re interested in the assumptions considered in this study, you can download the PDF brochure- https://www.marknteladvisors.com/query/request-sample/gastroesophageal-cancer-market.html

Strategic Takeaways from the Report:

Market Sizing and Forecasting
Regulatory and Policy Influence
Competitive Trends and M&A Activity
Innovation Drivers and Disruptive Technologies
Investment Hotspots and Emerging Niches
Geographical Dynamics and Trade Flows

Gastroesophageal Cancer Treatment Market Segment Overview & Classification

This market is categorized to offer targeted insights across various operational and consumer-related verticals.

Segment List:

By Indication

Squamous Cell Carcinoma
Adenocarcinoma

By Diagnosis

Endoscopy
Biopsy
Barium Swallow X-ray
CT/PET Scans
MRI

Upper endoscopy (esophagogastroduodenoscopy) is the most widely preferred diagnosis for gastroesophageal cancer. It is a fast procedure that helps medical professionals know the extent of the tumor by providing a detailed view of the esophagus, stomach, and duodenum (beginning of the small intestine).

By Treatment

Esophagectomy
Endoscopic Therapy
Chemotherapy
- Carboplatin
- Paclitaxel (Taxol)
- Oxaliplatin
- Capecitabine
- Cisplatin
- 5-fluorouracil (5-FU)
- Others
Radiation Therapy
- External-Beam Radiation Therapy (EBRT)
- Internal radiation therapy (Brachytherapy)
Immunotherapy
- Keytruda (Pembrolizumab)
- Opdivo (Nivolumab)
- Yervoy (Ipilimumab)
Targeted Therapy
- Trastuzumab
- Enhertu (Fam-trastuzumab deruxtecan)
- Ramucirumab
- Entrectinib
- Larotrectinib

Amongst all treatments, chemotherapy holds the largest share in the Global Gastroesophageal Cancer Treatment Market. It attributes to its higher cure rates & better efficiency than other therapies. Alongside radiation therapy & surgery, chemotherapy is used widely as an adjuvant treatment for gastroesophageal cancer.

By End-User

Hospitals
Clinics
Specialty Cancer Centers

By Region

North America
South America
Europe
Middle East & Africa
Asia-Pacific.

Among all regions globally, Asia-Pacific is expected to register high growth in the Gastroesophageal Cancer Treatment Market during 2022-27. It owes primarily to the growing patient pool of gastrointestinal diseases, coupled with massive investments in the healthcare infrastructure leading to the increasing multispecialty diagnostic centers with specialized cancer treatment options across the region. Moreover, the rapid increase in diagnostic procedures across countries like China, Japan, Indonesia, & Singapore, among others, is also expected to boost the regional market in the coming years.

These divisions help clarify demand patterns and expected shifts.

Gastroesophageal Cancer Treatment Market Competitive Snapshot from 2022-2027

The report highlights established and emerging players in the global Gastroesophageal Cancer Treatment Market, evaluating their strengths, challenges, and potential for innovation.

Key Competitors Include:

AstraZeneca PLC
Amgen Inc.
Bayer AG
Bristol Myers Squibb
Boehringer Ingelheim
Eli Lilly and Company
F. Hoffmann-La Roche AG
Gilead Sciences, Inc.
Merck & Co., Inc.
Novartis International AG
Pfizer Inc.
Sanofi S.A.
Others.

Their activities include partnerships, product launches, and geographic expansions.

Frequently Asked Questions (FAQs):

What industries are most impacted by this market?
How is technology reshaping operations and offerings?
Which competitors dominate the landscape?
What risks could disrupt market expansion?
How should businesses respond to demand fluctuations?

“Report Delivery Format: Market research reports from MarkNtel Advisors are available in PDF, Excel, and PowerPoint formats. Once payment is successfully processed, the report will be delivered to your email address within 24 hours”

Read Blog:

Note: If you need additional information not included in the report, we can customize it to suit your requirements. https://www.marknteladvisors.com/query/request-customization/gastroesophageal-cancer-market.html

Why Trust MarkNtel Advisors?

In-depth primary and secondary data validation
Focused on practical insights, not just raw numbers
Designed to support business strategy, not just reporting
Strong industry connections and real-time data flow
Transparent methodology and reliable sourcing

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India